Aurobindo Pharma reports a 10.2% YoY drop in Q1 FY26 PAT, citing API sales and US market revenue decline. The company's ...

Instead, tariffs have become a top issue for CEOs in recent months. Amid shifting global trade policies under the Trump ...

The defence stock has remained volatile in short-term. The stock fell over 10 per cent in a month, meanwhile, ascended over ...

IndusInd Bank said on Monday that it has approved the appointment of Rajiv Anand as its chief executive officer for a period of three years.

Q2 2025 Management View Daniel Patrick Penberthy, President and CEO, emphasized the challenging investment environment, stating that "the overall investment environment remained muted during this ...